Association of kidney and cardiovascular outcomes in patients with type 2 diabetes mellitus: insights from the EMPA-REG OUTCOME trial

被引：0
|
作者：
Sharma, A. [1 ]
Inzucchi, S. E. [2 ]
Testani, J. [3 ]
Ofstad, A. P. [4 ]
Fitchett, D. [5 ]
Mattheus, M. [6 ]
Verma, S. [7 ]
Zannad, F. [8 ]
Wanner, C. [9 ]
Kraus, B. J. [10 ]
机构：
[1] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
[4] Boehringer Ingelheim Norway KS, Asker, Norway
[5] Univ Toronto, St Michaels Hosp, Div Cardiol, Toronto, ON, Canada
[6] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[7] Univ Toronto, St Michaels Hosp, Div Cardiac Surg, Toronto, ON, Canada
[8] Univ Lorraine, CHRU Nancy, Ctr Invest Clin Plurithemat 1433, INSERM 1116,FCRIN,INI,CRCT, Nancy, France
[9] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany
[10] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [41] Empagliflozin Delays Need for Insulin Initiation in Patients with Type 2 Diabetes and Cardiovascular Disease: Findings from EMPA-REG OUTCOME
    Vaduganathan, Muthiah
    Sattar, Naveed
    Fitchett, David H.
    Ofstad, Anne Pernille
    Brueckmann, Martina
    George, Jyothis T.
    Verma, Subodh
    Mattheus, Michaela
    Wanner, Christoph
    Inzucchi, Silvio E.
    Zinman, Bernard
    Butler, Javed
    DIABETES, 2020, 69
  • [42] Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease: Survival Estimates From the EMPA-REG OUTCOME Trial
    Claggett, Brian
    Lachin, John M.
    Hantel, Stefan
    Fitchett, David
    Inzucchi, Silvio E.
    Woerle, Hans J.
    George, Jyothis T.
    Zinman, Bernard
    CIRCULATION, 2018, 138 (15) : 1599 - 1601
  • [43] Impact of EMPA-REG OUTCOME® on the management of type 2 diabetes mellitus: a review for primary care physicians
    Naing, Soe
    Poliyedath, Anupama
    Khandelwal, Stutee
    Sigala, Teresa
    POSTGRADUATE MEDICINE, 2016, 128 (08) : 822 - 827
  • [44] Empagliflozin improves renal outcomes in patients with or without heart failure at baseline - insights from the EMPA-REG OUTCOME trial
    Butler, J. Javed
    Zannad, F.
    Fitchett, D.
    Zinman, B.
    Koitka-Weber, A.
    Von Eynatten, M.
    Hehnke, U.
    George, J.
    Brueckmann, M.
    Cheung, A. K.
    Wanner, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 380 - 381
  • [45] How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
    Inzucchi, Silvio E.
    Zinman, Bernard
    Fitchett, David
    Wanner, Christoph
    Ferrannini, Ele
    Schumacher, Martin
    Schmoor, Claudia
    Ohneberg, Kristin
    Johansen, Odd Erik
    George, Jyothis T.
    Hantel, Stefan
    Bluhmki, Erich
    Lachin, John M.
    DIABETES CARE, 2018, 41 (02) : 356 - 363
  • [46] Cardiovascular outcomes according to LDL cholesterol levels in EMPA-REG OUTCOME
    Langslet, G.
    Zinman, B.
    Wanner, C.
    Hantel, S.
    Espadero, R. -M.
    Johansen, O. E.
    Fitchett, D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1192 - 1192
  • [47] CARDIOVASCULAR OUTCOMES ACCORDING TO LDL CHOLESTEROL LEVELS IN EMPA-REG OUTCOME
    Lee, Dae Wook
    Langslet, Gisle
    Zinman, Bernard
    Wanner, Christoph
    Hantel, Stefan
    Espadero, Rosa-Maria
    Johansen, Odd Erik
    Fitchett, David
    JOURNAL OF HYPERTENSION, 2016, 34 : E518 - E518
  • [48] Empagliflozin. Results of the EMPA-REG OUTCOME trial. A breakthrough in treatment of type 2 diabetes?
    Strojek, Krzysztof
    Rokicka, Dominika
    Szymborska-Kajanek, Aleksandra
    Wrobel, Marta
    CLINICAL DIABETOLOGY, 2016, 5 (03): : 107 - 110
  • [49] Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome Analysis of EMPA-REG OUTCOME using REDUCE-IT criteria
    Verma, Subodh
    Kosmopoulos, Andrew
    Bhatt, Deepak L.
    Fitchett, David
    Ofstad, Anne Pernille
    Wanner, Christoph
    Mattheus, Michaela
    Zinman, Bernard
    Lawler, Patrick R.
    Leiter, Lawrence A.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 15
  • [50] THE ASSOCIATION BETWEEN URIC ACID LEVELS AND CARDIORENAL OUTCOMES AND DEATH IN PATIENTS WITH TYPE 2 DIABETES: A SUB-ANALYSIS OF EMPA-REG OUTCOME
    Verma, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E45 - E45
12345